Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

Despite efforts by test maker Grail to highlight outcomes the company considers positive, some experts are warning against using the Galleri test and others like it.

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

The results of a new study just came in.

Blood tests are helpful for monitoring your overall health. But research suggests they can also give us clues about the ...

Another challenge facing test designers is that early detection may not necessarily save lives. A crucial factor, and something that is still unknown about the new multi-cancer tests, is whether they ...

A new light-based sensor detects cancer markers at near-zero concentrations.

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease.

A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it. The test, called Galleri, failed to lower the number of people diagnosed ...

I don’t have cancer of the pancreas. Receiving this result, after being the first Australian to undergo a revolutionary new ...

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...